Cargando…
Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
BACKGROUND: Malignant mesothelioma (MM) is a rare and highly aggressive cancer. Despite advances in multidisciplinary treatments for cancer, the prognosis for MM remains poor with no effective diagnostic biomarkers currently available. The aim of this study was to identify plasma metabolic biomarker...
Autores principales: | Gao, Yun, Dai, Ziyi, Yang, Chenxi, Wang, Ding, Guo, Zhenying, Mao, Weimin, Chen, Zhongjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740518/ https://www.ncbi.nlm.nih.gov/pubmed/35036082 http://dx.doi.org/10.7717/peerj.12568 |
Ejemplares similares
-
GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma
por: Wang, Ding, et al.
Publicado: (2023) -
A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
por: Chen, Zhongjian, et al.
Publicado: (2021) -
Combination of Plasma-Based Metabolomics and Machine Learning Algorithm Provides a Novel Diagnostic Strategy for Malignant Mesothelioma
por: Li, Na, et al.
Publicado: (2021) -
Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
por: Guo, Zhenying, et al.
Publicado: (2021) -
Proteins from Lignosus tigris with selective apoptotic cytotoxicity towards MCF7 cell line and suppresses MCF7-xenograft tumor growth
por: Kong, Boon Hong, et al.
Publicado: (2020)